Francesco Facchinetti

12PUBLICATIONS
161CO-AUTHORS
Molecular targetsHaematological tumoursLiquid biopsiesPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Feb 03, 2026
Recurrent Resistance Mutations to Lirafugratinib Inform Treatment Sequencing in FGFR2-Driven Tumors.

Francesco Facchinetti, Antoine Hollebecque, Rémy Barbé

|Sep 08, 2025
Systematic Engineering of TROP2-Targeted CAR T-Cell Therapy Overcomes Resistance Pathways in Solid Tumors.

Elliott J Brea, Simon Baldacci, Neil Savage

|Aug 05, 2025
Eradicating Drug-tolerant Persister Cells in EGFR-Mutated Non-Small Cell Lung Cancer by Targeting TROP2 with CAR-T Cellular Therapy.

Simon Baldacci, Elliott J Brea, Francesco Facchinetti

|Apr 09, 2025
Antitumor Activity of Vebreltinib and Characterization of Clinicogenomic Features in Solid Tumors with MET Rearrangements.

Seshiru Nakazawa, Federica Pecci, Igor Odintsov

|Sep 25, 2024
Transferrin receptor targeting chimeras for membrane protein degradation.

Dingpeng Zhang, Jhoely Duque-Jimenez, Francesco Facchinetti

|Sep 03, 2024
Understanding and Overcoming Resistance to Selective FGFR Inhibitors across FGFR2-Driven Malignancies.

Francesco Facchinetti, Yohann Loriot, Floriane Brayé

Pageof 2

Frequent Collaborators

5 joint publications

Damien Vasseur

4 joint publications

Luc Friboulet

4 joint publications

Pasi A Jänne

4 joint publications

Antoine Hollebecque